This fall and winter, Ontario, Quebec and Nunavut will offer the newer monoclonal antibody nirsevimab — approved by Health ...

Background: Since its introduction, palivizumab has been used to prevent respiratory syncytial virus (RSV) infection in high-risk populations. Recommendations for palivizumab administration ...

All palivizumab doses were given during or within 30 days of the RSV season, November 1 through April 1. During the pre-2014 guideline period, the rate of RSV hospitalizations in children younger ...

Getting vaccinated is one of the most effective ways to protect yourself and your loved ones from the flu, COVID-19 and RSV.

Respiratory Syncytial Virus (RSV) remains a critical health issue globally, particularly affecting vulnerable populations ...

RSV and the common cold both cause symptoms of viral infection. Coughing tends to be more severe in RSV. Learn how RSV vs.

For years, that antibody was palivizumab, which had to be given every month throughout the RSV season to maintain immunity. This fall and winter, Ontario, Quebec and Nunavut will offer the newer ...

Canada's vaccine advisers recommend RSV shots for infants Manitoba's largest hospital moving staff around due to high numbers of sick kids: Shared Health Manitoba currently offers palivizumab ...